Patient-driven Health Ecosystem
The current situation puts a bright light on the digitalization deficiencies of our health system. As the fight against COVID-19 continues, health organizations must find new ways of working.
Unprecedented speed in putting digital capabilities and an agile mindset in place is now required to adapt efficiently and deliver valuable solutions – not only for the actual crisis. Zühlke takes a leading role in contributing to these solutions, being it by developing a COVID-19 tracing app or generally speaking by encouraging and enabling the usage of the latest digital technologies in the pharmaceutical industry.
Attend our two online events
DIGITAL TECHNOLOGIES CAN HELP YOU TO
1. Accelerate clinical trials
Only 5% of all patients participate in clinical studies – and 30% of those participants drop out before all data is collected by the research group. This situation can be improved with the help of digital technologies.
With its UX and CX team, Zühlke can help you develop digital solutions that make participating in clinical trials easier while also ensuring a reliable trial setup and minimizing dropouts through providing an easy to use and inspiring frontend. With our experience in the handling and processing of data, we will support you in choosing an architecture for your clinical trial setups that is both easy to maintain and effortless. Embrace the “if you fail, fail fast” mentality and put your product to the test at the earliest possible stage – with the help of Zühlke experts.
2. Connect with patients
The share of clinical data with the pharmaceutical industry is hampered by a lack of trust along the society. Putting the patient into the center of all activities by giving them the control over their own data and offering improved patient outcomes with digital applications can help to build valuable relationships.
For decades, we have been offering valuable services and devices that provide added value for consumers and patients – and we will continue to do so, thereby helping you to get closer to the patient. With the help of our UX/CX team, medical devices/apps can become a communicative link between the pharma industry and the consumers. They will give you a chance to gain the patient’s trust.
3. Better understand diseases
The entrance of big tech companies changes the healthcare landscape as they take a user-centric and data-driven approach on healthcare. What is needed, however, is a smart combination of biological know-how and digital solutions.
We have highly trained and experienced specialists who know how to speak the languages of both worlds. They understand the biology and the needs of concepts such as GxP as well as cloud-based, scalable and safe architectures for data handling – and their expertise enables you to reach out and connect you to the world of the Big Tech companies. Together with our digital consultants, the cloud and platform experts and our UX/CX team, we will help you to raise your digital products and services to the next level, thus ensuring a fast time to market.
4. Efficiently treat diseases
Not only drugs can treat diseases, also software and medical apps can be used as part of therapies to improve health outcomes.
With our proven expertise in the development of SaMD for therapeutics and our excellent User Experience Team, we can design, develop and run your digital therapeutics idea. We understand the regulatory requirements with regard to developing products such as IEC 62366 and our cross-industry experience guarantees that your solution will be state-of-the art and loved by your users.
5. Measure outcome
Legislation, regulations and payers increasingly demand proof of the effectiveness and efficiency of pharmaceuticals and medical products. The solution to that could be digital biomarkers that can measure the health outcome in real time.
We have the technical competence to develop smart connected sensors in order to gather digital biomarkers – and we can also help you to directly engage with patients, using modern frontends and an outstanding user experience. This leads to a more efficient collecting of patient reported outcomes (PRO). Building and running production scale digital data platforms and using machine learning to generate valuable information from the collected data, we are the right partner for all pharmaceutical companies that want to get more insights into health outcomes – directly from the patients.
At Zühlke, we are happy to help you develop medical grade data algorithms, connect you with patients and gain their trust, realize medical grade devices, build digital health platforms and accelerate the time to market of your products.
WHY WE ARE THE RIGHT PARTNER
Innovation is our DNA. We support you in evaluating and realizing digital technologies within your organisation and product portfolio: we develop medical software, algorithms and devices customized for your specific needs. Customer satisfaction is our main goal, it is what drives us – and that is why we can look back onto more than 10.000 successful innovation projects during the last 50 years.
Strong partnerships with leading cloud providers such as Microsoft, Amazon and Google as well as a network of highly innovative partner companies guarantee that you get the technology that suits your demands.
- Top 5 pharma companies in Europe work with us
- Over 50 years of experience
- 1200 employees
- 176 nations
- 14 locations worldwide
- 10000 successful projects
- ISO 13485 compliant medical device development up to class III
Jan Horvat has a long track record in several strategic and operational management positions leading international product and software development alliances in the pharmaceutical and in various tech-industries. Together with his team, he is passionate about guiding healthcare clients to establish health-tech and digital business innovations along their patient´s and enterprise value chains.
When Daniel Diezi joined Zühlke in 2016, he already had acquired more than 12 years of global healthcare experience and led digital transformation projects internationally. As advisory board member of a digital health think-tank, the Swiss MedTech Association and as chairman of the MedTech & Pharma platform, he takes a leading role in shaping the future of health.
Having a PhD in physics from TU Wien, Dr. Nikolaus Kawka has a strong background in balancing business development and finding solutions in IT and Tech environments. He joined Zühlke as CEO of Zühlke Austria in 2011 and became a partner in 2018. Now, he is looking forward to reshaping healthcare in Austria through digital technology and help clients to face digital challenges together.